Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

ULSTED BIOGAS ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.3% 0.3%   Bankruptcy risk   2.7% 3.5% 1.6% 3.9% 9.5% 3.4% 14.7% 14.7%   Credit score (0-100)   62 54 74 49 25 53 14 14   Credit rating   BBB BBB A BBB BB BBB BB BB   Credit limit (kDKK)   0.0 0.0 5.8 0.0 -0.0 -0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   501 703 2,867 885 3,145 -73.9 0.0 0.0   EBITDA   -84.2 46.6 2,173 116 2,384 -402 0.0 0.0   EBIT   -1,044 -914 1,228 -870 -4,706 -755 0.0 0.0   Pre-tax profit (PTP)   -1,487.9 -1,385.3 747.7 -1,307.4 -5,501.7 -1,275.9 0.0 0.0   Net earnings   -897.9 -1,099.3 583.8 -1,020.1 -4,291.3 -995.2 0.0 0.0   Pre-tax profit without non-rec. items   -1,488 -1,385 748 -1,307 -5,502 -1,276 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   21,052 20,368 20,100 19,464 6,033 14,395 0.0 0.0   Shareholders equity total   3,216 2,117 2,701 1,680 -6,287 -881 -1,006 -1,006   Interest-bearing liabilities   17,256 17,766 17,775 18,218 20,969 19,196 1,006 1,006   Balance sheet total (assets)   23,347 23,859 23,403 22,268 16,311 18,898 0.0 0.0   Net Debt   17,256 16,913 17,121 18,218 20,969 19,183 1,006 1,006     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   501 703 2,867 885 3,145 -73.9 0.0 0.0   Gross profit growth   -75.7% 40.2% 307.8% -69.1% 255.2% 0.0% 0.0% 0.0%   Employees   0 0 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   23,347 23,859 23,403 22,268 16,311 18,898 0 0   Balance sheet change%   6.0% 2.2% -1.9% -4.9% -26.8% 15.9% -100.0% 0.0%   Added value   -84.2 46.6 2,172.8 116.3 -3,720.0 -401.9 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -947 -1,645 -1,212 -1,622 -16,027 3,296 -14,395 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -1.0 -2.0 1.0 -1.0 -2.0 -3.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -208.1% -130.0% 42.8% -98.3% -149.6% 1,021.2% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -4.6% -3.9% 5.2% -3.8% -21.0% -3.6% 0.0% 0.0%   ROI %   -5.1% -4.5% 6.1% -4.3% -23.0% -3.8% 0.0% 0.0%   ROE %   -24.5% -41.2% 24.2% -46.6% -47.7% -5.7% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   13.8% 8.9% 11.5% 7.5% -27.8% -4.5% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -20,496.9% 36,321.3% 788.0% 15,663.0% 879.5% -4,773.2% 0.0% 0.0%   Gearing %   536.6% 839.3% 658.2% 1,084.1% -333.5% -2,179.5% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   2.7% 2.7% 2.7% 2.4% 4.1% 2.6% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.2 0.3 0.3 0.3 0.8 0.4 0.0 0.0   Current Ratio   0.2 0.4 0.4 0.4 0.9 0.4 0.0 0.0   Cash and cash equivalent   0.0 853.0 654.3 0.0 0.0 13.1 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -7,010.2 -5,657.5 -4,803.6 -5,187.8 -1,723.8 -6,679.4 -502.9 -502.9   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 2,173 116 -3,720 -402 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 2,173 116 2,384 -402 0 0   EBIT / employee   0 0 1,228 -870 -4,706 -755 0 0   Net earnings / employee   0 0 584 -1,020 -4,291 -995 0 0